Your browser doesn't support javascript.
loading
Yersinia pseudotuberculosis Exploits CD209 Receptors for Promoting Host Dissemination and Infection.
He, Ying-Xia; Ye, Cheng-Lin; Zhang, Pei; Li, Qiao; Park, Chae Gyu; Yang, Kun; Jiang, Ling-Yu; Lv, Yin; Ying, Xiao-Ling; Ding, Hong-Hui; Huang, Hong-Ping; Mambwe Tembo, John; Li, An-Yi; Cheng, Bing; Zhang, Shu-Sheng; Zheng, Guo-Xing; Chen, Shi-Yun; Li, Wei; Xia, Lian-Xu; Kan, Biao; Wang, Xin; Jing, Huai-Qi; Yang, Rui-Fu; Peng, Hua; Fu, Yang-Xin; Klena, John D; Skurnik, Mikael; Chen, Tie.
Afiliação
  • He YX; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Ye CL; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Zhang P; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Li Q; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Park CG; Laboratory of Immunology, Brain Korea 21 PLUS Project for Medical Science, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yang K; Department of Pathogen Biology and Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
  • Jiang LY; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Lv Y; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Ying XL; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Ding HH; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Huang HP; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Mambwe Tembo J; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Li AY; Department of Paediatrics & Child Health, The University of Zambia-University College London Medical School at Zambia, Lusaka, Zambia.
  • Cheng B; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Zhang SS; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China.
  • Zheng GX; Department of Biomedical Science, College of Medicine-Rockford, University of Illinois at Chicago, Rockford, Illinois, USA.
  • Chen SY; Department of Biomedical Science, College of Medicine-Rockford, University of Illinois at Chicago, Rockford, Illinois, USA.
  • Li W; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Xia LX; Department of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
  • Kan B; Department of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
  • Wang X; Department of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
  • Jing HQ; Department of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
  • Yang RF; Department of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China.
  • Peng H; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Fu YX; Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Klena JD; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Skurnik M; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chen T; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland mikael.skurnik@helsinki.fi chentie@hust.edu.cn.
Infect Immun ; 87(1)2019 01.
Article em En | MEDLINE | ID: mdl-30348825
ABSTRACT
Yersinia pseudotuberculosis is a Gram-negative enteropathogen and causes gastrointestinal infections. It disseminates from gut to mesenteric lymph nodes (MLNs), spleen, and liver of infected humans and animals. Although the molecular mechanisms for dissemination and infection are unclear, many Gram-negative enteropathogens presumably invade the small intestine via Peyer's patches to initiate dissemination. In this study, we demonstrate that Y. pseudotuberculosis utilizes its lipopolysaccharide (LPS) core to interact with CD209 receptors, leading to invasion of human dendritic cells (DCs) and murine macrophages. These Y. pseudotuberculosis-CD209 interactions result in bacterial dissemination to MLNs, spleens, and livers of both wild-type and Peyer's patch-deficient mice. The blocking of the Y. pseudotuberculosis-CD209 interactions by expression of O-antigen and with oligosaccharides reduces infectivity. Based on the well-documented studies in which HIV-CD209 interaction leads to viral dissemination, we therefore propose an infection route for Y. pseudotuberculosis where this pathogen, after penetrating the intestinal mucosal membrane, hijacks the Y. pseudotuberculosis-CD209 interaction antigen-presenting cells to reach their target destinations, MLNs, spleens, and livers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Yersinia pseudotuberculosis / Moléculas de Adesão Celular / Lipopolissacarídeos / Receptores de Superfície Celular / Lectinas Tipo C / Endocitose / Interações Hospedeiro-Patógeno / Macrófagos Limite: Animals / Humans Idioma: En Revista: Infect Immun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Yersinia pseudotuberculosis / Moléculas de Adesão Celular / Lipopolissacarídeos / Receptores de Superfície Celular / Lectinas Tipo C / Endocitose / Interações Hospedeiro-Patógeno / Macrófagos Limite: Animals / Humans Idioma: En Revista: Infect Immun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China